freakoutcrazy

Blog des AK Psychiatriekritik der NFJ Berlin

Kategorie: Psychiatrie

Antidepressants, Pregnancy, and Autism: Why Wouldn’t Antidepressant Chemicals Affect a Developing Baby’s Brain?

This week another study was published (Boukhris, 2015) showing that SSRI antidepressant use during pregnancy is associated with increased rates of autism in the children.  By my count, this is now the tenth study on this topic and it follows on the heels of previous studies by Croen, Eriksson, Rai, Harrington, Gidaya, El Marroun and others – all of which found links between SSRI antidepressant use in pregnancy and autism in the offspring.  Most of these studies were recently reviewed by Man, et al, who also concluded that SSRI antidepressant use during pregnancy is associated with autism in the children.

So we now have numerous studies in different human populations all showing a link between SSRI use in pregnancy and autism in the children.  Yet, much of the news and blogosphere focus on casting doubts about these findings.  What is going on here?

MORE

Yes, the Tide is Turning Against Psychiatry

The suggestion embedded in this article’s title seems counter-intuitive. How could the tide be turning on psychiatry when the institution has never been so strong? And indeed indicators of its growing strength and tenacity are all around us. The exporting of its model to the global south via the World Bank, the emergence of outpatient committal, the explosion of funding for psychiatric research (see Burstow, 2015). Correspondingly, daily are there calls for most aggressive “detection” and “treatment”  (e.g., Jeffrey Lieberman, 2015). And the mainstream press has never been more closed to truly foundational critiques. That acknowledged, let me suggest that such intensification is common when an old system is in the early days of crumbling.

Of course, intensification itself is hardly an indicator that a reversal is at hand. So how would we know? Examples of possible indicators are: Ever growing critiques from inside and outside the profession, growing discomfort with “anomalies” (in essence, the indicators of a paradigm shift spelt out by Kuhn, 1962). Established moral authorities making unprecedented negative pronouncements about the current state of affairs. The surfacing of more and more tales of corruption and fraud. The rising up of those subjected to it. Each of these signs and more we are experiencing now with psychiatry — hardly conclusive individually, but taken together, convincing portents of a societal shift.

MORE

Crisis is (un)Learning

The mission statement for the Western Mass Recovery Learning Community’s (RLC) peer respite (Afiya) is:

“To provide a safe space in which each person can find the balance and support needed to turn what is so often referred to as ‘crisis’ into a learning and growth opportunity.”

Although I sometimes question our choice to use the word ‘safe’ (given how impossible an absolute version of ‘safe’ is to achieve and how saddled with distasteful meaning such a term can be within the mental health system), I’m not sure that statement could otherwise be any more straight forward and meaningful. Yet, so often, It’s unclear what meaning people are truly making of it.

MORE

My Response To Dr. Pies

In the October 2015 issue of The Behavior Therapist (pages 206-213), Jeffrey Lacasse, PhD, and Jonathan Leo, PhD, published an article titled Antidepressants and the Chemical Imbalance Theory of Depression: A Reflection and Update on the Discourse.

I thought the article had particular merit, and I drew attention to it in a post dated November 2.  The post, More on the Chemical Imbalance Theory, was also published on Mad in America.

In that post, I quoted a number of passages from the Behavior Therapist article, including:

MORE

NIMH Funding Changes Threaten Psychotherapy Research

The National Institute of Mental Health (NIMH) is increasingly shifting its research emphasis toward attempting to uncover biomarkers for “mental diseases,” which may have dramatic consequences for research and training in clinical psychology. In an article to be published in next month’s Professional Psychology: Research and Practice, Marvin Goldfried outlines how the shift in funding priorities for psychological research is tied to the needs of pharmaceutical companies and the biological model in psychiatry.

For nearly thirty years the NIMH has largely funded psychological research that utilized randomized control trials (RCTs) and tested “disorders” identified in the Diagnostic and Statistical Manual of Mental Disorders (DSM). Because the diagnostic categories listed in the DSM merely describe symptoms, this line of research rested on an “essentially weak empirical foundation.”

MORE